Outcomes after hematopoietic cell transplantation among non-English- compared to English-speaking recipients
Ahona Mukherjee(Fred Hutch Cancer Center), Stephanie J. Lee(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Chris Davis(Fred Hutch Cancer Center), K. Scott Baker(Malaria Consortium), Kathleen Shannon‐Dorcy(City Of Hope National Medical Center), Rachel B. Salit(Johns Hopkins Hospital), Elizabeth F. Krakow(Fred Hutch Cancer Center), Brenda M. Sandmaier(University of Washington), Masumi Ueda(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Leona Holmberg(University of Washington), Marco Mielcarek(Fred Hutch Cancer Center), Kris Doney(University of Washington), Ted Gooley(Fred Hutch Cancer Center)
Cited by 8
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
|Journal of Clinical Oncology|2006|2k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k